Diampa 25mg Tablet (Empagliflozin) – Maximum Strength SGLT2 Inhibitor for Type 2 Diabetes
Diampa 25mg Tablet (Empagliflozin) – Maximum Strength SGLT2 Inhibitor for Type 2 Diabetes
Diampa 25mg Tablet (Empagliflozin) – Maximum Strength SGLT2 Inhibitor for Type 2 Diabetes
Description
Diampa 25mg Tablet – Superior Glycemic Control with Enhanced Heart & Kidney Protection
Diampa 25mg Tablet delivers the higher 25mg dose of Empagliflozin, a leading SGLT2 inhibitor that effectively lowers blood sugar levels in adults with type 2 diabetes by removing excess glucose through urine. This maximum-strength formulation provides even greater HbA1c reduction while offering proven protection against cardiovascular events and slowing the progression of diabetic kidney disease. Ideal for patients needing stronger control, Diampa 25mg supports long-term health benefits when used with proper diet and exercise.
